Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
2020 | journal article. A publication with affiliation to the University of Göttingen.
Erratum to this publicationJump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
Sellner, L.; Schetelig, J. ; Koster, L.; Choi, G.; Blaise, D.; Beelen, D. & Schianca, F. C. et al. (2020)
Bone Marrow Transplantation, 55(12) pp. 2335-2338. DOI: https://doi.org/10.1038/s41409-020-0946-x
Documents & Media
Details
- Authors
- Sellner, Leopold; Schetelig, Johannes ; Koster, Linda; Choi, Goda; Blaise, Didier; Beelen, Dietrich; Schianca, Fabrizio Carnevale; Passweg, Jakob; Schanz, Urs; Gyan, Emmanuel; Sora, Federica; Kröger, Nicolaus; Wulf, Gerald. G. ; Van Gorkom, Gwendolyn; Mayer, Jiri; Orvain, Corentin; Bourhis, Jean Henri; Jindra, Pavel; Potter, Victoria; Zallio, Francesco; Vandenberghe, Elisabeth; Robinson, Stephen; Hayden, Patrick J.; Yakoub-Agha, Ibrahim; Montoto, Silvia; Dreger, Peter
- Issue Date
- 2020
- Journal
- Bone Marrow Transplantation
- ISSN
- 0268-3369
- eISSN
- 1476-5365
- Language
- English
